SCHEMBL9953863

SCHEMBL9953863

F[C](F)[C@@H](F)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.41
TDO2 P48775 2/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
AOC3 Q16853 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
ALPG P10696 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ORAI1 Q96D31 1/20 0.35
ORAI2 Q96SN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7798252 0.77 CHRNA7 (0.41) ALDH1A1LMNASMN1; SMN2ORAI1ORAI2
SCHEMBL695036 0.76 SRC (0.40) LMNACES2CES1
SCHEMBL9157493 0.75 HDAC3 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27845968 0.73 HDAC3 (0.45) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL4454516 0.72 IDO1 (0.44) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL4048358 0.71 IDO1 (0.48) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL27859843 0.70 HDAC3 (0.42) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL11603843 0.69 IDO1 (0.46) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL597442 0.69 IDO1 (0.46) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL7563025 0.69 IDO1 (0.46) IDO1TDO2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661428-A1 QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS Merck Sharp & Dohme Corp. (US) 2013-11-13 EP disclosed
WO-2012087861-A1 QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. (US) 2012-06-28 WO disclosed